Role of Ginkgo Biloba Extract in IUGR
NCT02425436 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 226
Last updated 2016-03-22
Summary
The use of herbal medicinal products is increasing enormously in recent years, mainly among women, who use them for the most varied purposes, such as in menstrual problems, menopausal symptoms, mood disturbances and to strengthen their bones. Most of these benefits are due to the flavonoids present in these products. These flavonoids have anticarcinogenic, antiviral, antioxidant and antiinflammatory activities, as well as being used in the treatment of osteoporosis, menopausal symptoms and cardiovascular diseases . Besides the benefits from the consumption of flavonoids, little is known about their safety and potentially harmful toxic effects, such as mutagenicity and genotoxicity which might occur if taken in large doses . Safety of Ginkgo biloba during pregnancy or lactation was not criticized in literature. Roasted and raw ginkgo seed were not reported in the evidence-based medicine literature as being either safe or contraindicated in pregnancy or lactation. A higher incidence of postpartum hemorrhage was reported in the literature when associated with a 3-month ingestion of Ginkgo Biloba extract. Flavonoids are components of Ginkgo biloba L. (Ginkgoaceae), a medicinal plant widely used by the population . G. biloba has its origin in China, Korea and Japan where its fruits and leaves have been used as food and medicine for a long time.
The extract of G. biloba (EGb) is composed of different terpene trilactones, i.e., ginkgolides A, B, C, J and bilobalide, many flavonol glycosides, biflavones and alkylphenols . The major flavonoids in the extract are kaempferol, quercetin and isorhamnetin\] whose metabolites were found in the blood of rats and in human urine after oral administration of EGb. Due to its actions as an anti-inflammatory and antioxidant, EGb has been largely used in the treatment of Alzheimer's disease, pre-menstrual syndrome, cerebrovascular insufficiency and peripheral arterial occlusive disease . In folk medicine, EGb is used as a vermifuge, to induce labor, for the treatment of bronchitis, chronic rhinitis, chilblains, arthritis and edema . The aim of this study was to evaluate the effect of oral supplementation of Ginkgo Biloba extract on the fetal weight as well as feto-maternal blood flow in cases of intrauterine growth restriction.
Conditions
- Intrauterine Growth Restriction (IUGR)
Interventions
- DRUG
-
Ginkgo Biloba Extract
- OTHER
-
Placebo
Sponsors & Collaborators
-
Assiut University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 35 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-05-31
- Primary Completion
- 2015-10-31
- Completion
- 2015-12-31
More Related Trials
-
Non-invasive Placental Chromosome Exploration of Intrauterine Growth Restriction
NCT05023161 ·Status: RECRUITING
-
Transplacental Aspirin Therapy for Early Onset Fetal Growth Restriction
NCT04557475 ·Status: WITHDRAWN ·Phase: PHASE3
-
The Effect of Oral Isosorbide Mononitrate Therapy on Umbilical Artery Doppler Resistance Index in Pregnancies With Intrauterine Growth Restriction: Prospective Randomized Control Trial
NCT05800938 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Steroids on Maternal Glucose Levels
NCT03021837 ·Status: COMPLETED
-
Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy
NCT04356326 ·Status: RECRUITING ·Phase: PHASE3
-
Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers
NCT01729468 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Fetal Movement Counting in Third Trimester of Pregnancy
NCT00513942 ·Status: COMPLETED ·Phase: NA
-
Immunosuppressant Regimens for Living Fetuses Study
NCT03671174 ·Status: UNKNOWN ·Phase: NA
-
The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss
NCT02990403 ·Status: UNKNOWN ·Phase: PHASE4
-
Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients
NCT01875107 ·Status: WITHDRAWN ·Phase: PHASE4
-
Progesterone for First Trimester Vaginal Bleeding
NCT01501890 ·Status: WITHDRAWN ·Phase: NA
-
Longitudinal Study of Intra-Uterine Growth Restriction
NCT02382601 ·Status: RECRUITING
-
Hydroxychloroquine for Prevention of Recurrent Miscarriage.
NCT03165136 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Steroid Hormones, TH1/TH2 Cytokines and Reproductive Status
NCT00001376 ·Status: COMPLETED
-
Hydroxychloroquine and Unexplained Recurrent Miscarriage
NCT04228263 ·Status: COMPLETED ·Phase: NA
-
Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial.
NCT02280031 ·Status: COMPLETED ·Phase: PHASE2
-
Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy
NCT05186779 ·Status: TERMINATED
-
The Efficacy of Aspirin Combined With Hydroxychloroquine Treatment in High Risk Pregnancies for Preeclampsia
NCT05287321 ·Status: RECRUITING ·Phase: PHASE3
-
Diagnosis and Management of Intrauterine Growth Restriction and Congenital Anomalies
NCT03398629 ·Status: RECRUITING
-
The Effect of Iron Deficiency Anemia During Pregnancy
NCT02590224 ·Status: COMPLETED ·Phase: PHASE4
-
Antenatal Platelet Response on Aspirin: a Pharmacokinetic Study Through Pregnancy
NCT04645004 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Pharmacology of 17-OHPC in Pregnancy
NCT00409825 ·Status: COMPLETED ·Phase: PHASE2
-
RCT on the Efficacy of Methotrexate for the Prevention of GTD
NCT01984099 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Early Screening Test for Pre-eclampsia and Growth Restriction
NCT03674606 ·Status: COMPLETED ·Phase: PHASE4
-
Improving Mothers for a Better PrenAtal Care Trial Barcelona
NCT03166332 ·Status: COMPLETED ·Phase: NA